×

Growth Reports

Growth Reports
Report Name

HER-2 Positive Breast Cancer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Chemotherapy, Targeted Therapy Immunotherapy, Others), By Route of Administration (Oral, Parenteral, Others), By End-User (Hospitals, Homecare, Specialty Clinics, Others), Countries and Companies Report

HER-2 Positive Breast Cancer Market is projected to register a 9.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022281  |   No. of Pages: 195

HER2 - Negative Breast Cancer Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Chemotherapy , Radiation , Hormonal Therapy , Others), By Drug (Biologics, Small molecules), Countries and Companies Report

HER2 - Negative Breast Cancer Market is projected to register a 10.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022280  |   No. of Pages: 196

HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Monotherapy, Combination therapy), By Distribution Channel (Retail pharmacies, Hospital pharmacies, Online pharmacies), Countries and Companies Report

HER2 (Human Epidermal Growth Factor Receptor 2) Inhibitors Market is projected to register a 11.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022279  |   No. of Pages: 203

Hepatocellular Carcinoma Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug Class (PD-1/PD-L1 Inhibitors, Atezolizumab, Avelumab, Durvalumab, Tyrosine Kinase Inhibitors, Gefitinib, Erlotinib, Sorafenib), By Treatment (Medication, Surgery, Radiotherapy, Chemotherapy, Others), By Route of Administration (Oral, Injectable, Others), By End-User (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Countries and Companies Report

Hepatocellular Carcinoma Drugs Market is projected to register a 7.5% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022278  |   No. of Pages: 194

Hepatitis Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Route of Administration (Oral, Injection), By End-User (Hospitals, Clinics, Others), Countries and Companies Report

Hepatitis Drugs Market is projected to register a 2.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022277  |   No. of Pages: 198

Hepatitis C Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (NS5A Inhibitor, Fixed-dose Combination, Others), By Therapy (Combination Therapy, Monotherapy), By Disease (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), Countries and Companies Report

Hepatitis C Drugs Market is projected to register a 1.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022276  |   No. of Pages: 204

Hepatitis B Vaccines Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Combination Vaccines, Single Antigen Hepatitis B Vaccines), By End-User (Hospitals, Clinics, Others), Countries and Companies Report

Hepatitis B Vaccines Market is projected to register a 4.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022275  |   No. of Pages: 190

Hepatitis B Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Anti-Virals, Hepatitis B Vaccine), By Therapy (Chemo Therapy, Immunosuppressant Therapy, Nucleoside Analogue), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Countries and Companies Report

Hepatitis B Therapeutics Market is projected to register a 4.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022274  |   No. of Pages: 194

Hepatitis B and C Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Immunodiagnostics, NAT), By Disease (Hepatitis B, Hepatitis C), Countries and Companies Report

Hepatitis B and C Diagnostics Market is projected to register a 5.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022273  |   No. of Pages: 197

Hepatic Encephalopathy (HE) Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Kits, Reagents, Instruments), By Application (Type A (acute liver failure), Type B (portal systemic Bypass without liver disease), Type C (liver cirrhosis)), Countries and Companies Report

Hepatic Encephalopathy (HE) Therapeutics Market is projected to register a 8.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD00022272  |   No. of Pages: 190

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us